HealthEquity, Inc. (HQY) Stock Forecast
HQY analyst forecast
as of October 18, 2026- Analyst consensus
- Strong buy 4.67 / 5 from 15 analysts
- Price target
- $119.33 average of analyst targets
- Upside to target
- +29.7% from the latest close
- Next earnings
- December 2, 2026 EPS estimate $0.96
- 52-week range
- $73.21 – $106.79
HQY analyst ratings
15 analystsNumber of analysts at each rating.
HQY price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
HQY earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Oct '26) | $1.15 | $1.13 | $1.19 | $1.01 | +13.9% | 14 |
| Current fiscal year (FY2027) | $4.72 | $4.70 | $4.76 | $4.00 | +18.1% | 14 |
| Next fiscal year (FY2028) | $5.50 | $5.25 | $6.01 | $4.72 | +16.4% | 14 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
HQY revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Oct '26) | $347.2M | $344.9M | $350.1M | +7.8% | 14 |
| Current fiscal year (FY2027) | $1.42B | $1.41B | $1.42B | +7.9% | 14 |
| Next fiscal year (FY2028) | $1.53B | $1.49B | $1.56B | +7.7% | 14 |
HQY EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
HQY revenue: reported and forecast
HQY EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Oct '26) | $1.15 | $1.15 | $1.15 | $1.15 | $1.15 | −0.3% | 5 up · 6 down |
| Current fiscal year (FY2027) | $4.72 | $4.72 | $4.72 | $4.72 | $4.72 | +0.1% | 7 up · 2 down |
| Next fiscal year (FY2028) | $5.47 | $5.45 | $5.49 | $5.50 | $5.50 | +0.6% | 7 up · 4 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
HQY earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; HQY beat in 11 of 12.
What analysts expect from HQY
15 analysts cover HealthEquity; their consensus rating is strong buy (4.67 on a 1–5 scale, where 5 is a strong buy). The average price target is $119.33, 29.7% above the latest close of $92.03. Analysts expect earnings of $4.72 per share for FY2027, +18.1% from a year earlier. For FY2028 the average estimate is $5.50 per share on revenue of $1.5 billion. HealthEquity beat the EPS estimate in 11 of the last 12 quarters.
Related: HQY income statement, HQY key metrics, HQY chart. See the HQY stock overview for the latest quote and news.
HQY forecast FAQ
What is HealthEquity's price target?
The average analyst price target for HealthEquity is $119.33, 29.7% above the latest close of $92.03.
Is HealthEquity a buy, hold or sell?
Of 15 analysts covering HealthEquity, 10 rate it a strong buy, 5 a buy, 0 a hold, 0 a sell and 0 a strong sell, a consensus of strong buy. Ratings are opinions, not a recommendation from Quotelinks.
What is HealthEquity's EPS forecast?
Analysts forecast $4.72 per share for FY2027 (range $4.70 to $4.76); for FY2028 the estimate is $5.50.
What is HealthEquity's revenue forecast?
The average revenue estimate for FY2027 is $1.4 billion, growth of 7.9%; for FY2028 it is $1.5 billion.
When does HealthEquity report earnings?
HealthEquity is expected to report results for the quarter ending October 31, 2026 on December 2, 2026 before the market opens; the EPS estimate is $0.96.
Does HealthEquity usually beat earnings estimates?
HealthEquity reported EPS at or above the analyst estimate in 11 of the last 12 quarters.